Support and safety
Official Resources
A compact hub for primary sources, help lines, and treatment-finder links.
Why Official Sources Come First
Kratom information online is unusually noisy [1, 2, 3]. Vendor pages may be promotional, community forums may be emotionally useful but anecdotal, and generic health pages may smooth uncertainty into false confidence [1, 2, 3].
Official sources provide the safest public-health baseline [1, 2, 3]. They are not a complete lived-experience map, but they are the right starting point for claims about safety, dependence, withdrawal, product variability, and help-seeking [1, 2, 3, 4].
Kratom Science and Public-Health Context
NIDA's kratom page is the best first stop for federal research context [1]. It explains kratom's stimulant-like and opioid-like reported effects, the role of mitragynine and 7-OH, reported reasons for use, dependence concerns, and what remains uncertain [1].
NCCIH's NIH kratom page gives a plain-language overview of reported uses and safety concerns [2]. It is useful for balancing the reality that people use kratom for perceived benefits with the reality that evidence for medical use remains insufficient [2].
FDA's kratom page is the key regulatory source [3]. It covers FDA's position that kratom is not approved for any medical use and discusses product safety, adverse events, and public-health concerns [3].
FDA's 7-OH consumer update is especially important for powder-only education because it warns consumers to avoid products containing added or enhanced 7-OH and describes them as novel potent opioid products [4].
FDA's heavy metals testing page is relevant when discussing product-quality uncertainty [5]. It should be used carefully: it supports concerns about contamination in some tested products, not a claim that every powder is contaminated [5].
Help and Treatment Resources
SAMHSA's National Helpline provides free, confidential, 24/7 treatment referral and information for mental health and substance use concerns [6].
FindTreatment.gov is SAMHSA's locator for mental health and substance use treatment services in the United States [7].
The 988 Suicide & Crisis Lifeline provides 24/7 support for suicidal crisis or emotional distress [8].
Poison Help connects people in the U.S. to local poison centers and may be relevant for suspected poisoning, adverse exposure, or urgent product-reaction questions [9].
Clinical Background Sources
NCBI Bookshelf withdrawal references can help explain opioid-withdrawal physiology, red flags, and supportive care [10]. These sources are indirect for kratom and should be labeled that way when used [1, 10].
Peer-reviewed kratom studies are useful when they address kratom directly, including real-world use patterns, dose-effect relationships, pharmacokinetics, and withdrawal case literature [11, 12, 13].
Community Context Sources
Community guides can help identify what users actually ask about: scale use, pre-weighed doses, dose timing, taper holds, vitamin C protocols, exercise, and cold turkey timelines [A1, A2, A3]. Those sources should stay in separate "Anecdotal Context, Not Evidence" sections [A1, A2, A3].
Community material does not support efficacy, safety, withdrawal timelines, supplement claims, or medical triage [A1, A2, A3]. It can only support statements like "people discuss this," "some users report this pattern," or "community guides often emphasize this practical tactic" [A1, A2, A3].
References
- NIDA / NIH: Kratom
- NCCIH / NIH: Kratom
- FDA: FDA and Kratom
- FDA: Products Containing 7-OH Can Cause Serious Harm
- FDA: Laboratory Analysis of Kratom Products for Heavy Metals
- SAMHSA: National Helpline
- SAMHSA: FindTreatment.gov
- SAMHSA: 988 Suicide & Crisis Lifeline
- HRSA: Poison Help
- Shah and Huecker, 2023: Opioid Withdrawal, StatPearls, NCBI Bookshelf
- Smith et al., 2022: Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships
- Smith et al., 2024: Ecological Momentary Assessment of Self-Reported Kratom Use
- Trakulsrichai et al., 2015: Pharmacokinetics of mitragynine in man